Zolmax Deep Medicine Acquisition Corp. (NASDAQ:DMAQ Get Free Report) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totalling 12,300 shares, a growth of 1,437.5% from the July 15th total of 800 shares. Approximately 3.7% of the companys stock ...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nDeep Medicine Acquisition (DMAQ) stock is climbing higher on Wednesday after the SPAC provided an update on its merger plans.\nThe...\n more…
Zolmax Deep Medicine Acquisition Corp. (NASDAQ:DMAQ Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,300 shares, a growth of 1,200.0% from the June 15th total of 100 shares. Currently, 0.4% of ...\n more…
Ticker Report Glazer Capital LLC boosted its position in shares of Deep Medicine Acquisition Corp. (NASDAQ:DMAQ Get Rating) by 219.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 45,682 shares of the companys stock after acquiring an additional 31,393 shares ...\n more…